What risks come with methotrexate treatment?
Methotrexate can cause side effects and complications because it affects rapidly dividing cells and can build up in the body if dosing or clearance is impaired. The main risks fall into a few groups: liver and lung injury, blood cell suppression, kidney-related toxicity, and safety concerns around pregnancy and breastfeeding.
Liver, lungs, and blood: the biggest medical concerns
Liver toxicity is a known risk with methotrexate, especially with long-term use or in people who drink alcohol or already have liver disease. Pulmonary toxicity (lung inflammation or scarring) can also occur, sometimes presenting as a new or worsening cough or shortness of breath. Blood cell suppression is another important risk, which can lead to infections, anemia, or easy bruising.
These risks are why clinicians typically monitor blood counts and organ function during treatment.
Kidney issues can raise the risk of methotrexate toxicity
Because methotrexate is cleared through the kidneys, impaired kidney function can increase drug exposure and side-effect risk. Dehydration or certain drug combinations can also raise levels, making monitoring and dose adjustments important.
Drug interactions that increase danger
Some medicines can increase methotrexate levels or worsen its toxicity. Common interaction types include:
- Other drugs that affect kidney clearance
- Drugs that also suppress bone marrow
- Certain antibiotics and anti-inflammatory medications used alongside methotrexate (some combinations can be risky)
Clinicians often check the full medication list (including over-the-counter products) before starting and during therapy.
Pregnancy and fertility: a major risk category
Methotrexate is generally considered unsafe during pregnancy because it can cause birth defects and pregnancy loss. It is also a concern for people trying to conceive, so pregnancy planning and contraception guidance are typically required before and during treatment.
Infection and vaccination considerations
Because methotrexate can suppress parts of the immune system, it can increase susceptibility to infections in some people. Patients are usually advised to contact their clinician if they develop fever, signs of infection, or severe illness symptoms.
Which patients are at higher risk?
Risk is higher for people with:
- Pre-existing liver or lung disease
- Kidney impairment
- Alcohol use (for liver risk)
- Prior abnormal blood counts
- Use of interacting medications
- Higher methotrexate doses and long treatment durations
Are there “warning signs” that mean you should seek help?
Seek urgent medical care for symptoms that can indicate serious complications, such as:
- Shortness of breath, persistent cough, or chest pain
- Vomiting, severe diarrhea, or inability to keep fluids down
- Fever or signs of infection
- Unusual bruising, bleeding, or marked fatigue (possible blood suppression)
- Yellowing of skin/eyes or dark urine (possible liver injury)
How are risks managed during methotrexate therapy?
Clinicians manage risk through baseline assessment and ongoing monitoring, typically including blood tests (for blood counts) and liver and kidney function tests. Dose adjustments, folic acid supplementation (commonly used to reduce some side effects), and careful review of drug interactions are frequent parts of safe prescribing.
If you share your methotrexate dose, schedule (e.g., weekly), the condition being treated, and any other medications you take, I can help flag the most relevant risk areas to discuss with your clinician.